Metraipolis › archive › dc_90dee2352913

From the Optic Neuritis Treatment Trial to Antibody-Mediated Optic Neuritis: Four Decades of Progress and Unanswered Questions — Europe PMC PMID:41751233

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41751233
DOI
10.3390/biomedicines14020334
License (as archived)
solo-consultazione
Archived
2026-11-06T09:28:55.002Z
SHA-256 of the archived text
bf758d5b644446f3cc25c67a8a49727ebd159b69af15ad4aaf390e906f040775
Stable URL of this page
https://metraipolis.com/documento/dc_90dee2352913

How to cite

From the Optic Neuritis Treatment Trial to Antibody-Mediated Optic Neuritis: Four Decades of Progress and Unanswered Questions — Europe PMC PMID:41751233 — Europe PMC (en), https://europepmc.org/article/MED/41751233 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_90dee2352913 (Metraipolis archive dc_90dee2352913, sha256 bf758d5b644446f3cc25c67a8a49727ebd159b69af15ad4aaf390e906f040775)
BibTeX
@misc{dc90dee2352913,
  title = {From the Optic Neuritis Treatment Trial to Antibody-Mediated Optic Neuritis: Four Decades of Progress and Unanswered Questions — Europe PMC PMID:41751233},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41751233},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_90dee2352913; sha256 bf758d5b644446f3cc25c67a8a49727ebd159b69af15ad4aaf390e906f040775},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41751233. Agents can read the archived copy with the MCP tool read_document.